Formulación y biodisponibilidad de nuevos medicamentos
Universidade de São Paulo
São Paulo, BrasilPublicacións en colaboración con investigadores/as de Universidade de São Paulo (6)
2023
-
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
Pharmaceutics, Vol. 15, Núm. 11
2021
-
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
Journal of Immunology Research, Vol. 2021
2020
-
Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis
International Journal of Pharmaceutics, Vol. 588
-
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases
ACS Infectious Diseases, Vol. 6, Núm. 10, pp. 2647-2660
2019
-
Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis
Pharmaceutics, Vol. 11, Núm. 7
2018
-
Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis
Medical Mycology, Vol. 56, Núm. 3, pp. 288-296